Raised INR with concurrent warfarin and azithromycin

Australian Journal of Hospital Pharmacy

Volumn 29, Issue 3, 1999, Pages 159-161

  Wiese, Michael D ^a  

^a ROYAL HOBART HOSPITAL   (Australia)

Author keywords

[No Author keywords available]

Indexed keywords

AZITHROMYCIN; VITAMIN K GROUP; WARFARIN;

AGED; ARTICLE; BLOOD CLOTTING TIME; CASE REPORT; HUMAN; INTERNATIONAL STANDARD UNIT; INTRAVENOUS DRUG ADMINISTRATION; LABORATORY TEST; LIVER FUNCTION TEST; MALE; ORAL DRUG ADMINISTRATION; VITAMIN METABOLISM;

EID: 0033015652     PISSN: 03106810     EISSN: None     Source Type: Journal    
DOI: 10.1002/jppr1999293159     Document Type: Article

References (5)

1. Vdall JA. Human sources and absorption of vitamin K in relation to anticoagulation stability. JAMA 1965; 194: 127-9.
2. O'Reilly RA, Aggeler PM. Determinants of the response to oral anticoagulant drugs in man. Pharmacol Rev 1970; 22: 36-96.
3. Periti P, Mazzei T, Mini E, Novelli A. Pharmacokinetic drug interactions of macrolides. Clin Pharmacokinet 1992; 23: 106-31.
4. Wiebert RT, Lorentz SM, Townsend RJ, Cook CE, Klauber MR, Jagger PI. Effect of erythromycin in patients receiving long-term warfarin therapy. Clin Pharm 1989; 8: 210-14.
5. Byers M. Clarithromycin-warfarin interaction resulting in an elevated INR. Can J Hosp Pharm 1997; 50: 285-7.